Literature DB >> 34096581

Diagnostic Accuracy of Salivary Metanephrines in Pheochromocytomas and Paragangliomas.

Karin Eijkelenkamp1, Thamara E Osinga1, Martijn van Faassen2, Ido P Kema2, Michiel N Kerstens1, Karel Pacak3, Wim J Sluiter1, Thera P Links1, Anouk N A van der Horst-Schrivers1,4.   

Abstract

BACKGROUND: Measurements of plasma free metanephrines are recommended for diagnosing pheochromocytomas and paragangliomas (PPGL). Metanephrines can be detected in saliva with LC-MS/MS with sufficient analytical sensitivity and precision. Because collecting saliva is noninvasive and less cumbersome than plasma or urine sampling, we assessed the diagnostic accuracy of salivary metanephrines in diagnosing PPGL.
METHODS: This 2-center study included 118 healthy participants (44 men; mean age: 33 years (range: 19--74 years)), 44 patients with PPGL, and 54 patients suspected of PPGL. Metanephrines were quantified in plasma and saliva using LC-MS/MS. Diagnostic accuracy; correlation between plasma and salivary metanephrines; and potential factors influencing salivary metanephrines, including age, sex, and posture during sampling, were assessed.
RESULTS: Salivary metanephrines were significantly higher in patients with PPGL compared with healthy participants (metanephrine (MN): 0.19 vs 0.09 nmol/L, P < 0.001; normetanephrine (NMN): 2.90 vs 0.49 nmol/L, P < 0.001). The diagnostic sensitivity and specificity of salivary metanephrines were 89% and 87%, respectively. Diagnostic accuracy of salivary metanephrines was 88%, with an area under the ROC curve of 0.880. We found a significant correlation between plasma and salivary metanephrines (Pearson correlation coefficient: MN, 0.86, P < 0.001; NMN, 0.83, P < 0.001). Salivary NMN concentrations were higher when collected in a seated position compared with supine (P < 0.001) and increased with age (P < 0.001).
CONCLUSIONS: Salivary metanephrines are a promising tool in the biochemical diagnosis of PPGL. Salivary metanephrines correlate with plasma free metanephrines and are increased in patients with PPGL. At this time, however, salivary metanephrines cannot replace measurement of plasma free metanephrines. © American Association for Clinical Chemistry 2021. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34096581      PMCID: PMC8341008          DOI: 10.1093/clinchem/hvab064

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   12.167


  18 in total

1.  Mass spectrometric quantification of salivary metanephrines-A study in healthy subjects.

Authors:  Thamara E Osinga; Anouk N A van der Horst-Schrivers; Martijn van Faassen; Michiel N Kerstens; Robin P F Dullaart; Karel Pacak; Thera P Links; Ido P Kema
Journal:  Clin Biochem       Date:  2016-02-10       Impact factor: 3.281

2.  Blood sampling for metanephrines comparing venipuncture vs. indwelling intravenous cannula in healthy subjects.

Authors:  Karin Eijkelenkamp; Eva H van Geel; Michiel N Kerstens; Martijn van Faassen; Ido P Kema; Thera P Links; Anouk N A van der Horst-Schrivers
Journal:  Clin Chem Lab Med       Date:  2020-09-25       Impact factor: 3.694

3.  Reference intervals for LC-MS/MS measurements of plasma free, urinary free and urinary acid-hydrolyzed deconjugated normetanephrine, metanephrine and methoxytyramine.

Authors:  Graeme Eisenhofer; Mirko Peitzsch; Denise Kaden; Katharina Langton; Anastasios Mangelis; Christina Pamporaki; Jimmy Masjkur; Aikaterini Geroula; Max Kurlbaum; Timo Deutschbein; Felix Beuschlein; Aleksander Prejbisz; Stefan R Bornstein; Jacques W M Lenders
Journal:  Clin Chim Acta       Date:  2018-12-17       Impact factor: 3.786

4.  Biochemical Diagnosis of Chromaffin Cell Tumors in Patients at High and Low Risk of Disease: Plasma versus Urinary Free or Deconjugated O-Methylated Catecholamine Metabolites.

Authors:  Graeme Eisenhofer; Aleksander Prejbisz; Mirko Peitzsch; Christina Pamporaki; Jimmy Masjkur; Natalie Rogowski-Lehmann; Katharina Langton; Elena Tsourdi; Mariola Pęczkowska; Stephanie Fliedner; Timo Deutschbein; Felix Megerle; Henri J L M Timmers; Richard Sinnott; Felix Beuschlein; Martin Fassnacht; Andrzej Januszewicz; Jacques W M Lenders
Journal:  Clin Chem       Date:  2018-08-10       Impact factor: 8.327

5.  Catecholamines in human saliva.

Authors:  B Kennedy; E Dillon; P J Mills; M G Ziegler
Journal:  Life Sci       Date:  2001-05-25       Impact factor: 5.037

6.  Age-specific pediatric reference intervals for plasma free normetanephrine, metanephrine, 3-methoxytyramine and 3-O-methyldopa: Particular importance for early infancy.

Authors:  Mirko Peitzsch; Anastasios Mangelis; Graeme Eisenhofer; Angela Huebner
Journal:  Clin Chim Acta       Date:  2019-03-20       Impact factor: 3.786

7.  Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline.

Authors:  Jacques W M Lenders; Quan-Yang Duh; Graeme Eisenhofer; Anne-Paule Gimenez-Roqueplo; Stefan K G Grebe; Mohammad Hassan Murad; Mitsuhide Naruse; Karel Pacak; William F Young
Journal:  J Clin Endocrinol Metab       Date:  2014-06       Impact factor: 5.958

Review 8.  Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension.

Authors:  Jacques W M Lenders; Michiel N Kerstens; Laurence Amar; Aleksander Prejbisz; Mercedes Robledo; David Taieb; Karel Pacak; Joakim Crona; Tomáš Zelinka; Massimo Mannelli; Timo Deutschbein; Henri J L M Timmers; Frederic Castinetti; Henning Dralle; Jřri Widimský; Anne-Paule Gimenez-Roqueplo; Graeme Eisenhofer
Journal:  J Hypertens       Date:  2020-08       Impact factor: 4.844

9.  Pheochromocytoma and Paraganglioma Susceptibility Genes: Estimating the Associated Risk of Disease.

Authors:  Lauren Fishbein; Katherine L Nathanson
Journal:  JAMA Oncol       Date:  2017-09-01       Impact factor: 31.777

10.  Supine or sitting? Economic considerations regarding patient position during plasma metanephrine analysis for the exclusion of chromaffin tumours.

Authors:  Vasileios Chortis; Irina Bancos; Rachel K Crowley; Wiebke Arlt
Journal:  Clin Endocrinol (Oxf)       Date:  2014-09-25       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.